Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
Acceptability of Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
1 other identifier
observational
102
0 countries
N/A
Brief Summary
The aim of this pre-post observational study is to explore if it is feasible to implement 1) routine mental health screening and b) an online Cognitive Behavioural Therapy (CBT) treatment for anxiety and/or depression (named COMPASS-MS) for people living with Multiple Sclerosis (MS) (PwMS) and co-morbid psychological distress in routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2023
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedJanuary 24, 2024
October 1, 2023
1 year
November 3, 2023
January 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Psychological Distress (primary outcome for a future full scale trial).
The investigators will measure general psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). This includes 9 items from the Patient Health Questionnaire and 7 items from the Generalised Anxiety Disorder Scale. Each item is responded to on a 4-point Likert Scale (0-3) (minimum score: 0, maximum score: 48). Higher scores indicate higher levels of depression and anxiety.
baseline and 12 week follow up
Secondary Outcomes (12)
Reach of screening and COMPASS MS intervention
Baseline only
Reach of screening and COMPASS MS intervention
Baseline only
Reach of screening and COMPASS MS intervention
Baseline only
Reach of screening and COMPASS MS intervention
Baseline only
Efficacy: psychological outcomes
baseline and 12 week follow up
- +7 more secondary outcomes
Interventions
Digital CBT to treat psychological distress in Multiple Sclerosis (MS)
Eligibility Criteria
People living with Multiple Sclerosis (MS) and co-morbid psychological distress Healthcare professionals and Key stakeholders of people living with MS and co-morbid psychological distress
You may qualify if:
- Key Stakeholders from Neurology services external to KCH will be invited to take part in an interview if they meet all or any of the below criteria:
- Work in a Neurology Service in England including both inpatient services and MS therapy centres.
- Have direct patient experience with working with PwMS (e.g. Neurologist, Doctor, Nurse, Reception)
- Work alongside a Neurology services in England and are involved in the care of PwMS (e.g. pharmacy/physiotherapy/commissioning bodies).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- King's College Hospital NHS Trustcollaborator
Related Publications (8)
Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, Monahan PO. Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials. Psychosom Med. 2016 Jul-Aug;78(6):716-27. doi: 10.1097/PSY.0000000000000322.
PMID: 27187854BACKGROUNDCarleton RN, Norton MA, Asmundson GJ. Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. J Anxiety Disord. 2007;21(1):105-17. doi: 10.1016/j.janxdis.2006.03.014. Epub 2006 May 2.
PMID: 16647833BACKGROUNDRimes KA, Chalder T. The Beliefs about Emotions Scale: validity, reliability and sensitivity to change. J Psychosom Res. 2010 Mar;68(3):285-92. doi: 10.1016/j.jpsychores.2009.09.014. Epub 2009 Dec 9.
PMID: 20159215BACKGROUNDEuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.
PMID: 10109801BACKGROUNDMundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4. doi: 10.1192/bjp.180.5.461.
PMID: 11983645BACKGROUNDRyan EG, Vitoratou S, Goldsmith KA, Chalder T. Psychometric Properties and Factor Structure of a Long and Shortened Version of the Cognitive and Behavioural Responses Questionnaire. Psychosom Med. 2018 Feb/Mar;80(2):230-237. doi: 10.1097/PSY.0000000000000536.
PMID: 29023262BACKGROUNDStuifbergen A, Becker H, Blozis S, Beal C. Conceptualization and development of the Acceptance of Chronic Health Conditions Scale. Issues Ment Health Nurs. 2008;29(2):101-14. doi: 10.1080/01612840701792548.
PMID: 18293219BACKGROUNDThornicroft, G. (2001). An adapted version of the Client Service Receipt Inventory. Costing psychiatric interventions. London: Measuring Mental Health Needs.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2023
First Posted
January 24, 2024
Study Start
February 1, 2024
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
January 24, 2024
Record last verified: 2023-10